The Food and Drug Administration denied an emergency use authorization for fluvoxamine as a SARS-CoV-2 antiviral. Fluvoxamine was proposed as a possible antiviral in 2021 due to its mechanisms of ...

Transitioning COVID-19 tests from emergency use authorization to the traditional pre-market pathway has long been a goal for the FDA. “Today’s authorization is the first at-home COVID-19 test granted ...

Please provide your email address to receive an email when new articles are posted on . Labcorp has received FDA emergency use authorization for its Mpox PCR Test Home Collection Kit. This test is now ...

InflaRx had been pursuing development of vilobelimab in other indications beyond COVID, but the company’s hopes for the asset ...

Pfizer announced on Thursday that its COVID vaccine booster shot could further protect individuals from "all currently known variants" of COVID-19 — including the highly transmittable Delta variant.

The Novavax COVID-19 Vaccine is administered intramuscularly as a 2-dose primary series (0.5mL each), separated by 3 weeks. The Food and Drug Administration (FDA) has granted Emergency Use ...

Moderna announced Tuesday that it has begun the rolling submission process for full approval of its COVID-19 vaccine in adults from the U.S. Food and Drug Administration. The manufacturer will ...

Thirty percent of unvaccinated American adults say they’re waiting for the COVID-19 vaccines currently authorized for emergency use to be officially approved by the U.S. Food and Drug Administration.

The first COVID-19 vaccine was distributed under an emergency use authorization on Dec. 11. More than seven months later, full approval hasn’t been granted to that vaccine or the two others that have ...

Nov 1 (Reuters) - Novavax Inc (NVAX.O), opens new tab expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its chief executive told ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab ...